Skip to main content

Table 4 Infections requiring antibiotics for patients who discontinued treatment after 6 months of LOT initiation

From: Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study

Variable

LOT1 (n = 126)

LOT2 (n = 79)

LOT3 (n = 38)

LOT4 (n = 19)

Abatacept (n = 12)

Other bDMARD (n = 114)

Abatacept (n = 12)

Other bDMARD (n = 67)

Abatacept (n = 8)

Other bDMARD (n = 30)

Abatacept (n = 7)

Other bDMARD (n = 12)

Infections (requiring antibiotics)

 Experienced event (%)

a

27 (23.7%)

a

18 (26.9%)

a

13 (43.3%)

a

5 (41.7%)

 Discontinued treatment (%)

a

27 (23.7%)

a

18 (26.9%)

0 (0.0%)

12 (40.0%)

a

5 (41.7%)

  1. LOT Line of therapy
  2. aCells suppressed due to small numbers